Menezes Cássio Campello de, Vieira Joaquim Edson
Divisão de Anestesiologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo.
Rev Bras Anestesiol. 2002 Nov;52(6):728-38.
The prevalence of asthma is increasing and anesthesiologists may start seeing this clinical manifestation more often in the perioperative period. This study aimed at investigating different bronchospasm management techniques during anesthesia.
A questionnaire was mailed to a stratified sample of 108 anesthesiologists from the Anesthesiology Society of State of São Paulo (SAESP). Questions involved individual bronchospasm statistics and management, clinical evolution, professional experience and the management of patients with upper airway infection (UAI).
After mailing three stratified samples (324 questionnaires), 73 questionnaires were returned with a reported bronchospasm incidence of 0.90%. Management techniques were: steroids (90.41%), halogenates (68.49%), teophylline (50.68%), inhalational beta2-agonists (47.95%) and epinephrine (41.10%). Most anesthesiologists would discontinue general (84.93%) or regional anesthesia (64,38%) in UAI patients.
The diversity of reported treatments indicate the need for spreading international protocols on asthma treatment and control, emphasizing the specific use of inhalational beta2- agonists and steroids.
哮喘的患病率正在上升，麻醉医生在围手术期可能会更频繁地遇到这种临床表现。本研究旨在调查麻醉期间不同的支气管痉挛管理技术。
向圣保罗州麻醉学会（SAESP）的108名麻醉医生的分层样本邮寄了一份问卷。问题涉及个人支气管痉挛的统计数据与管理、临床进展、专业经验以及上呼吸道感染（UAI）患者的管理。
在邮寄了三个分层样本（324份问卷）后，共收回73份问卷，报告的支气管痉挛发生率为0.90%。管理技术包括：类固醇（90.41%）、卤化物（68.49%）、茶碱（50.68%）、吸入性β2受体激动剂（47.95%）和肾上腺素（41.10%）。大多数麻醉医生会在UAI患者中停止全身麻醉（84.93%）或区域麻醉（64.38%）。
所报告治疗方法的多样性表明需要推广国际哮喘治疗和控制方案，强调吸入性β2受体激动剂和类固醇的具体使用。
